Hepatic steatosis, although higher in MetS than in non-MetS iCCA, did not reach statistical significance ( Figure 2 ).
← all excerpts
Intrahepatic Cholangiocarcinoma Developing in Patients with Metabolic Syndrome Is Characterized by Osteopontin Overexpression in the Tumor Stroma.
1
—
—